Peginesatide Side Effects
Applies to peginesatide: injectable solution
General side effects have included pyrexia (12.2%).[Ref]
Immunologic side effects have included the development of peginesatide specific antibodies (1.2%).[Ref]
Other side effects have included arteriovenous fistula site complication (16.1%).[Ref]
Hypersensitivity side effects have included postmarketing reports of serious allergic reactions including fatal reactions (0.02%).
1. "Product Information. Omontys (peginesatide)." Takeda Pharmaceuticals America, Lincolnshire, IL.
More about peginesatide
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Drug class: recombinant human erythropoietins
- FDA Alerts (1)
- Other brands
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.